Huang Qizhao, Xu Lifan, Ye Lilin
Institute of Immunological Innovation and Translation, Chongqing Medical University, Chongqing, China; Guangdong Provincial Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
Institute of Immunology, Third Military Medical University, Chongqing, China; National Key Laboratory of Trauma and Chemical Poisoning, Third Military Medical University, Chongqing, China.
Curr Opin Immunol. 2025 Feb;92:102506. doi: 10.1016/j.coi.2024.102506. Epub 2024 Nov 26.
Accumulating evidence demonstrates that tumor-specific CD8 T cells in tumor-draining lymph nodes (TdLNs) act as an upstream reservoir of exhausted subsets within tumor microenvironment (TME). This reservoir primarily consists of progenitor exhausted CD8 T (T) cells and newly defined tumor-specific memory subsets (T). We propose that these two subsets work together to mediate the antitumor effects of PD-1/PD-L1 immune checkpoint blockade (ICB) in a spatiotemporal manner. Although PD-1/PD-L1 ICB monotherapy drives the proliferation and further differentiation of these subsets, it does not alter the programmed differentiation trajectory from T cells to T cells, ultimately leading to the development of terminally exhausted CD8 T cells. This phenomenon may partly explaining the frequent relapse in patients following initial ICB therapy. In this review, we focus on the phenotypic and functional heterogeneity of tumor-specific CD8 T cells in both TdLNs and the TME and discuss the implications of these studies for ICB. Our insights aim to illuminate new strategies for advancing tumor immunotherapies.
越来越多的证据表明,肿瘤引流淋巴结(TdLNs)中的肿瘤特异性CD8 T细胞是肿瘤微环境(TME)中耗竭亚群的上游储存库。这个储存库主要由祖细胞耗竭性CD8 T(T)细胞和新定义的肿瘤特异性记忆亚群(T)组成。我们提出,这两个亚群共同发挥作用,以时空方式介导PD-1/PD-L1免疫检查点阻断(ICB)的抗肿瘤作用。虽然PD-1/PD-L1 ICB单药治疗驱动这些亚群的增殖和进一步分化,但它不会改变从T细胞到T细胞的程序性分化轨迹,最终导致终末耗竭性CD8 T细胞的产生。这种现象可能部分解释了初始ICB治疗后患者频繁复发的原因。在这篇综述中,我们重点关注TdLNs和TME中肿瘤特异性CD8 T细胞的表型和功能异质性,并讨论这些研究对ICB的意义。我们的见解旨在阐明推进肿瘤免疫治疗的新策略。